Skip to main content
. 2020 Nov 9;45(1):151–158. doi: 10.3892/or.2020.7841

Figure 3.

Figure 3.

S100A8 is closely associated with the drug resistance of BCL cells. (A) RT-qPCR analysis was performed to detect the mRNA expression of S100A8 in BCL cells. (B and C) Western blotting for S100A8 protein expression in BCL cells. (D) RT-qPCR analysis was performed to confirm gene interference in the S100A8 expression in BCL cells. (E and F) Cells were treated with ADR or VCR following S100A8 interference. Cell viability was analyzed by the Cell Counting Kit-8 assay. ***P<0.001, **P<0.01 and *P<0.05. BCL, B-cell lymphoma; RT-qPCR, reverse transcription quantitative PCR; ADR, Adriamycin; VCR, vincristine.